Senseonics Wins Marketing Authorization For Novel Insulin Delivery System

The US FDA has cleared a glucose monitoring system from Senseonics. The authorization of the implantable insulin delivery system creates a new pathway for like devices.

Diabetes
• Source: Shutterstock

More from Regulation

More from Policy & Regulation